Pfizer
PFE
2,940 hedge funds and large institutions have $95.2B invested in Pfizer in 2025 Q1 according to their latest regulatory filings, with 178 funds opening new positions, 1,288 increasing their positions, 1,204 reducing their positions, and 191 closing their positions.
5% more funds holding in top 10
Funds holding in top 10: 42 → 44 (+2)
7% more repeat investments, than reductions
Existing positions increased: 1,288 | Existing positions reduced: 1,204
2% more capital inflows, than outflows
Capital inflows: $8.49B | Capital outflows: $8.33B
0.02% more ownership
Funds ownership: 66.26% → 66.27% (+0.02%)
7% less first-time investments, than exits
New positions opened: 178 | Existing positions closed: 191
2% less funds holding
Funds holding: 3,005 → 2,940 (-65)
23% less call options, than puts
Call options by funds: $2.98B | Put options by funds: $3.87B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$950M |
| 2 |
BlackRock
New York
|
+$587M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$470M |
| 4 |
Amundi
Paris,
France
|
+$412M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$342M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
-$2.81B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$955M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$429M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$261M |
| 5 |
Two Sigma Advisers
New York
|
-$239M |
PFE Hedge Fund Activity: Q1 2025 in Review
2,940 of the 7,482 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2025, worth a combined $95.2B — down 4.4% from $100B a quarter earlier.
Sellers outnumbered buyers: 191 funds closed out of PFE and 178 opened new positions — a net loss of 13 holders — while 1,204 trimmed existing stakes and 1,288 added.
The largest buyer was Fisher Asset Management, adding an estimated $950M. The largest seller was Charles Schwab, cutting an estimated $2.81B.
- 2,940 institutional investors held Pfizer (PFE) as of Q1 2025, down from 3,005 in Q4 2024.
- Funds reported $95.2B of Pfizer stock for Q1 2025, down 4.4% quarter-over-quarter.
- 178 funds opened new Pfizer positions in Q1 2025 and 191 closed out, a net change of -13 holders.
- The largest Pfizer buyer in Q1 2025 was Fisher Asset Management, an estimated $950M added.
- The largest Pfizer seller in Q1 2025 was Charles Schwab, an estimated $2.81B sold.
Based on aggregated 13F filings for Q1 2025.